LDN Social Media
Get connected with us on social networks
Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)
Molds make mycotoxins that often are toxic to humans and animals. Mold toxicity is very important, but difficult to understand and difficult to deal with. Dr. Weinstock talks about some medications, but there are no FDA approved mycotoxin therapies. He discusses cases of patients with mold toxicity as evidenced with mast cell activation syndrome (MCAS).
The relationship of mold exposure and asthma is well documented. Hypersensitivity pneumonitis is a very severe condition that can occur from mold exposure. Damage to brain cells or to nerves also. Autoimmune antibodies can develop from mycotoxins as the mold multiplies, making the immune system go wild. It's known that there are mycotoxins that are carcinogenic.
Dr. Weinstock discusses how mold passes into the body, and several effects of this. He also presents relevant laboratory studies and some treatments, including the role for LDN.
KEYWORDS: mycotoxins, mold, mast cell activation syndrome (MCAS), inflammation, toxin, macrophages, asthma, mold toxicity, autoimmune, low dose naltrexone (LDN), pain, neuralgia, SIBO, Parkinson's, autism
This is a summary of the presentation. Watch the video for full information.